Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic pulses to the brain: a new hope for veterans with PTSD?

NCT ID NCT04207346

Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether transcranial magnetic stimulation (TMS) — a non-invasive treatment that uses magnetic fields to stimulate specific brain areas — can improve daily functioning in veterans with PTSD. Researchers compared real TMS to a sham (fake) treatment in 59 veterans. The goal was to see if TMS could reduce PTSD symptoms and help veterans get back to normal activities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

59 people

The number who actually took part.

Started

Dec 2020

Finished

Sep 2025

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age between 19 and 70 2. Moderate to severe PTSD as determined by the CAPS within 7 days of randomization. 3. Agree to have CAPS audio-recorded. 4. Ability to obtain a Motor Threshold using the TMS device during screening. 5. Patient eligible for VA healthcare. 6. If female with childbearing potential, use of acceptable method of birth control (i.e., use of contraceptives, abstinence). 7. Able to read, understand, and sign the informed consent document. Exclusion Criteria: 1. Pregnant or lactating woman. 2. Current use of clozapine (any dose) or bupropion (more than 300mg per day). 3. Cardiac pacemaker or implantable defibrillator. 4. Presence of any metal object in the head, including cochlear implants, but excluding dental work in the mouth. 5. Significant central nervous system disorder (stroke, brain mass, epilepsy). 6. Seizure in past one year. 7. Current psychosis or mania. 8. Prior use of TMS. 9. Significant suicidal ideation. 10. Unstable medical conditions. 11. Current alcohol or substance use disorder (except nicotine) that interferes with the patient's ability to participate. 12. CPT or PE for PTSD in the past 2 months. 13. Changes in Fluoxetine, Paroxetine, Sertraline, or Venlafaxine in the past 2 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PTSD

Contacts and locations

Locations

  • White River Junction VA Medical Center, White River Junction, VT

    White River Junction, Vermont, 05001-3833, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.